2024 ACMT | Annual Scientific Meeting

2024 ACMT | Annual Scientific Meeting

  • Registration Closed

2024 ACMT Annual Scientific Meeting


April 12-14, 2024
Omni Shoreham Hotel, Washington, DC

The ACMT Annual Scientific Meeting (ASM) is an opportunity for specialists in the field to gather together to learn from the cutting-edge research of their peers. In addition to all the networking and social opportunities that make our events so rich with engagement, this year ACMT is piloting concurrent sessions offering more educational content than ever before! These concurrent sessions will be divided into the following topical tracks of broad interest to the Medical Toxicology community: 1) Environmental & Occupational Medicine, 2) Addiction Medicine, 3) Diversity, Equity & Inclusion, and 4) Research.

Learning Objective 1
Enhance clinical decision-making in the field of Medical Toxicology.

Learning Objective 2
Summarize knowledge of emerging toxins and novel therapies.

Learning Objective 3
Organize multidisciplinary collaboration in the management of complex medical toxicology cases.

View Agenda


Continuing Education

Continuing Medical Education (CME), Continuing Pharmacy Education (CPE) and Continuing Nursing Education (CNE) credits are available for this activity for an additional fee. To receive continuing education credits, learners must attend the sessions in-person or watch them on-demand after the event.

Purchase CE


Book Hotel

ACMT has secured a discounted rate at the Omni Shoreham Hotel in Washington, DC for attendees of our 2024 ACMT Annual Scientific Meeting. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!

Book Attendee Hotel


Key Dates

Accepting Abstract Submissions: September 1 - November 15, 2023
Early Bird Registration Opens: October 2, 2023
MTF Spadafora, Shannon, J&J Travel Award Deadlines: October 2, 2023
Becker Medal Deadline: October 27, 2023
Abstract Student/Resident and International Travel Awards Deadline: November 15, 2023 (Abstract deadline)
MedTox Shark Tank Research Forum application deadline: December 4, 2023
MedTox Case Panel application deadline: December 18, 2023
Abstract Notifications: Mid December 2023
Open Mic Competition application deadline: January 15, 2024
Early Bird Registration Ends: February 20, 2024
2024 ACMT: April 12-14, 2024


Questions?

Please write to ACMT at events@acmt.net

Agenda

This agenda is subject to change. All times listed are in local, Eastern Time Zone.


Friday, April 12, 2024


7:45 - 8:00 AM - Welcome & Introductions


8:00 - 9:00 AM - Platform Session 1


9:00 - 9:45 AM

Donovan Lectureship | Groundbreaking Research from NIDA Addressing the Challenges of the Opioid Epidemic

Nora D. Volkow, MD, Director, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), Washington, DC

This lectureship is supported by the Medical Toxicology Foundation through the Ward and Ryan Donovan Memorial Fund. For more info, please visit: www.acmt.net/donovan-lectureship


9:45 - 10:45 AM

Chemical Defense: Assessing and Optimizing Local Responses

Mark Kirk, MD, Senior Advisor, Chemical Defense, DHS Countering Weapons of Mass Destruction, Department of Homeland Security, Washington, DC

The Past, Present, and Future of Contributions of the United States Army Medical Research Institute of Chemical Defense to Chemical Casualty Care

Daniel Nogee, MD, MHS, Medical Toxicologist, Chemical Casualty Care Division, U.S. Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, MD


10:45 - 11:45 AM - Poster Session 1
10:55 - 11:35 AM - Moderated Poster Forum 1


11:45 - 1:00 PM - Break / Committee Meetings



Tracks 1:00-1:30 PM ET - Concurrent Sessions
Pick one to attend live, watch the others on-demand after (if available)
Availability
Environmental & Occupational 
Medicine
Harmful Algal Blooms (HABs): What Poison Centers and Medical Toxicologists Should Know

Brett E. Johnson, MD, Emergency Medicine Physician, UMass Memorial Medical Center, Worcester, MA
Mindy Richlen, PhD, Research Specialist, Biology, Woods Hole Oceanographic Institution, Woods Hole, MA
Michael J. Twiner, MD, PhD, Department of Emergency Medicine, Wayne State University, Detroit, MI

Moderator:  Jeffrey Lai, MD, Assistant Professor of Emergency Medicine, UMass Memorial, Worcester, MA

Live
+
On-Demand
Addiction
Medicine
Medication for Opioid Use Disorder Trajectory Phenotypes: Development of a Risk Stratification and Prediction Framework Using Urine Toxicology and EHR Data

Albert Burgess-Hull, PhD, Head Data Scientist, MATClinics, University of Maryland, Baltimore, MD

Live
+
On-Demand
Diversity, Equity
& Inclusion

The Toxic Past and Present of Redlining and Racial Segregation

Sean D. McCann, MD, Assistant Professor of Clinical Emergency Medicine and Medical Toxicology, University of Illinois Chicago, Chicago, IL

Moderator:  Noah Berland, MD, MS, Assistant Division Director Medical Toxicology, Kings County Hospital, Newark, NJ

Live
+
On-Demand
Research
Researchers, Do You Even R? Getting Started with Managing and Visualizing Toxicology Data in R

Hannah Spungen, MD, MPH, Toxicology Fellow, Banner University Medical Center-Phoenix, Phoenix, AZ

Live
+
On-Demand


1:30 - 1:40 PM ET - Break / Transition Time

Tracks 1:40-2:10 PM ET - Concurrent Sessions
Pick one to attend live, watch the others on-demand after (if available)
Availability
Environmental & Occupational 
Medicine
Mad About Manganese: Medical Toxicologists and Water Quality Standards

Richard Hamilton, MD, MBA, FACMT, FACEP, FAAEM, Professor and Chair of Emergency Medicine, Drexel University College of Medicine Philadelphia, PA

Live
+
On-Demand
Addiction
Medicine
The Public Health Impact of Over-The-Counter Naloxone & Nalmefene

Michael Toce, MD, MS, FACMT, Assistant Professor of Pediatric and Emergency Medicine, Harvard Medical School, Boston, MA

Live
+
On-Demand
Diversity, Equity
& Inclusion

The Good, Bad and Ugly: Drug Testing in Liver Transplant Evaluations

Speakers
Victor Chen, MD, PhD, Assistant Professor of Medicine, Johns Hopkins Medicine, Lutherville, MD
Jason Wheatley, LCSW-C, Clinical Transplant Social Worker II, Johns Hopkins Comprehensive Transplant Center, Baltimore, MD

Moderators

Robert Cole Pueringer, MD, Medical Toxicologist and Addiction Medicine Specialist, Essentia Health, Duluth, MN
JoAn Laes, MD, FACMT, FASAM, Abbott Northwestern Hospital, Allina Health, Minneapolis, MN

Live
ONLY
Research
Translational Approach to Biomarker and Therapeutic Development in Environmental Toxicology

David Jang, MD, MSc, FACMT, Assistant Professor, University of Pennsylvania School of Medicine, Philadelphia, PA

Live
ONLY


2:10 - 2:20 PM ET - Break / Transition Time

Tracks 2:20-2:50 PM ET - Concurrent Sessions
Pick one to attend live, watch the others on-demand after (if available)
Availability
Environmental & Occupational 
Medicine
Do You Really Know IARC? Why IARC Determinations Aren’t Clear Cut, and When They Result in Controversy 

John Downs, MD, MPH, Associate Professor and Associate Program Director, Occupational & Environmental Medicine Residency, Uniformed Services University, Bethesda, MD
Kevin F. Maskell, Jr., MD, Assistant Professor of Military and Emergency Medicine, Brooke Army Medical Center, Jbsa Ft Sam Houston, TX

Live
+
On-Demand
Addiction
Medicine

Psilocybin and the Treatment of Substance Use Disorder

Albert Garcia-Romeu, PhD, Assistant Professor, Behavioral Pharmacology Research Unit, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD

Live
ONLY
Diversity, Equity
& Inclusion

Toxicology Practice and Gender and Sexual Minorities

Sarah Weiss, MD, MBS, Director of Medical Toxicology, Reading Hospital, Tower Health, Sinking Spring, PA

Live
+
On-Demand
Research
Translational Research from Laboratory Bench to Clinical Practice: Digoxin Poisoning

Betty Shuk Han Chan, MBBS, PhD A/Prof, Prince of Wales Hospital, Sydney, Australia

Live
+
On-Demand


2:50 - 3:00 PM ET - Break / Transition Time

Tracks 3:00-3:30/45 PM ET - Concurrent Sessions
Pick one to attend live, watch the others on-demand after (if available)
Availability

Environmental & Occupational 
Medicine
Testing and Counseling on Polyfluoroalkyl Substances (PFAS) exposure in the Medical Toxicology Clinic

Nicholas Erick Nacca, MD, Assistant Professor of Emergency Medicine, University of Rochester Medical Center, Rochester, NY
John Downs, MD, MPH, Associate Professor and Associate Program Director, Occupational & Environmental Medicine Residency, Uniformed Services University, Bethesda, MD
Elizabeth Boyle, MPH, CIH, Senior Program Officer, Board on Population Health and Public Health Practice, National Academies of Sciences, Engineering, and Medicine, Washington, DC

Moderator: Michael Holland, MD, FACMT, FAACT, FEACCT, FACOEM, FACEP, SUNY Upstate Medical University, Syracuse, NY

Note: to accommodate additional speakers this session has been extended and will now be 45 min (3:00-3:45 PM ET)

Live
+
On-Demand
Addiction
Medicine
Annual Review of Medical Toxicology Publications - Articles You May Have Missed from 2023-2024

Dan McCabe, MD, Director of the Division of Medical Toxicology & Associate Medical Director, University of Iowa & Iowa Poison Control Center, Iowa City, IAM/p>

Live
+
On-Demand

Diversity, Equity
& Inclusion

Trauma-Informed Care for the Medical Toxicologist

Vinodinee L. Dissanayake, MD, MPH, Assistant Professor, Department of Emergency Medicine, Rush University Medical Center, Chicago, IL
Antonia Nemanich, MD, Assistant Professor, Rush University Medical Center, Chicago, IL
Jenna Nikolaides, MD, MA, FACEP, Assistant Professor, Department of Emergency Medicine, Rush University Medical Center, Chicago, IL
Trevonne Thompson, MD, FACEP, FACMT, Associate Dean of Admissions, University of Illinois College of Medicine at University of Illinois at Chicago, Chicago, IL

Live
ONLY

Research
Anatomy of Authorship

Mark Mycyk, MD, Editor in Chief; Research Chair, Journal of Med Tox; Cook County Health, Chicago, IL

Live
+
On-Demand

3:30/45 - 5:00 PM - Break / Committee Meetings


5:00 - 6:00 PM - ACMT Annual Members Meeting and Awards Ceremony


6:00 - 8:00 PM - President's Reception


Saturday, April 13, 2024


7:45 - 8:00 AM - Morning Announcements


8:00 - 9:00 AM - Platform Session 2


9:00 - 9:45 AM

Panel | Toxicological Considerations of the East Palestine, Ohio Train Derailment

Joseph Cocciardi, PhD, MS, FAIHA, CIH, CSP, REHS/RS, Founding Principal, Cocciardi and Associates, Inc.; Senior Health & Safety Professional, Pennoni, Mechanicsburg, PA 
Michael Kosnett, MD, MPH, FACMT, Associate Clinical Professor, Department of Environmental & Occupational Health, University of Colorado School of Medicine and School of Public Health, Denver, CO
Charles McKay, MD, FACMT, Associate Medical Director, Connecticut Poison Control Center, University of Connecticut School of Medicine, Marlborough, CT
Joshua Shulman, MD, Medical Director, Pittsburgh Poison Center; Assistant Professor, University of Pittsburgh, Pittsburgh, PA

Moderator: Emily Kiernan, DO, FACEP, Assistant Professor, Emory University, Atlanta, GA


9:45 - 10:30 AM

ACMT Career Achievement Award | Medical Toxicology at the FDA: A Structured Public Health Career

Keith Burkhart, MD, Senior Advisor for Medical Toxicology, US Department of Health and Human Services, Silver Spring, Maryland


10:30- 11:30 AM - Poster Session 2
10:40 - 11:20 AM - Moderated Poster Forum 2


11:30 - 1:00 PM - Break / Committee Meetings


1:00 - 2:00 PM

AACT Panel | Don’t Have a Meltdown: What Toxicologists Need to Know About Radiation Exposure and Contamination

Emily Kiernan, DO, FACEP, Assistant Professor, Emory University, Atlanta, GA

Moderator: Kathryn Kopec, DO, FACMT, Associate Professor, Division Director of Medical Toxicology, Carolinas Medical Center, Charlotte, NC

Developed in Collaboration with the American Academy of Clinical Toxicology (AACT).


2:00 - 3:30 PM - MedTox Case Panel - Case-based Conundrums


3:30 - 5:00 PM - MTF Shark Tank Research Forum


5:00 - 7:00 PM - Open Mic Competition


Sunday, April 14, 2024


7:50 - 8:00 AM - Morning Announcements


8:00 - 9:00 AM - Lightning Oral Session


9:00 - 10:45 AM

International Panel

MENATOX: Chlorine Gas Incident in Sohar: Lessons Learned
Hassan Al Balushi, MD, OMSB-EM, Emergency Medicine Consultant and Medical Toxicologist, Suhar Hospital, Minitry of Health, Oman

APAMT: Asian vs. Australian Snakebite: An Evolutionary Divide
Geoff Isbister, MD, Professor, School of Medicine and Public Health, University of Newcastle, Australia

EAPCCT: Drug Toxicity from Pharmaceutical Production Processes
Mark Lawrence Zammit, B.Pharm (Hons.), MSc, Visiting Senior Lecturer, Department of Clinical Pharmacology and Therapeutics, University of Malta; Advanced Pharmacy Practitioner, Ministry for Health, Malta

IST: The Odyssey of Antidote Stockpiling: The Case of The Leiurus Hebraeus Scorpion and Beyond
Ophir Lavon, MD, Head, Clinical Pharmacology and Toxicology Unit, Carmel Medical Center, Chair, Israel Society of Toxicology, Haifa, Israel

RETOMEX: The Challenges of Envenomations in Mexico
Jorge Guillermo Perez Tuñon, MD, Head of Clinical Toxicology Service & Certified Pediatrician, Angeles Lomas Hospital, Mexico City, Mexico

Developed in Collaboration with the Middle East & North Africa Clinical Toxicology Association (MENATOX), Asia Pacific Association of Medical Toxicology (APAMT), the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT), Israeli Society of Toxicology (IST), and Red de Toxicología Mexicana (RETOMEX).


10:45 - 11:00 AM - Break (15 min)


11:00 - 12:00 PM

ASAM Panel | NIDA Research & ED Experience with XR Injectable Buprenorphine

Kristen Huntley, PhD, Associate Director, Addiction Medicine Team Leader, Center for the Clinical Trials Network, National Institute on Drug Abuse, NIH, DHHS, Washington, DC
Gail D'Onofrio, MD, MS, Albert E. Kent Professor of Emergency Medicine, Professor of Epidemiology (Chronic Diseases) and Professor of Medicine Core Addiction, Yale School of Medicine, New Haven, CT
Joseph Carpenter, MD, Assistant Professor, Department of Emergency Medicine, Emory University School of Medicine, Atlanta, GA
Jon Cole, MD, FACMT, Emergency Physician and Medical Toxicologist, Hennepin County Medical Center; Medical Director, Minnesota Poison Control System, Minneapolis, MN

Moderator
Timothy Wiegand, MD, FACMT, FAACT, DFASAM, Associate Professor of Emergency Medicine and the Director of Toxicology and the Toxicology/Addiction Consult Service, Strong Memorial Hospital, University of Rochester Medical Center, Rochester, NY

Developed in Collaboration with the National Institute on Drug Abuse (NIDA) and the American Society of Addiction Medicine (ASAM).


12:00 - 12:45 PM

Achieving Health Equity in the Field of Substance Use: A Public Health Approach

Carla Foster, MPH, Epidemiologist and Principal Investigator, New York City Department of Health and Mental Hygiene, New York, NY


12:45 - 1:45 PM - Poster Session 3
12:55 - 1:35 PM - Moderated Poster Forum 3

Committee Meetings Schedule

This schedule is subject to change. All times listed are in local, Eastern Time Zone.


Thursday, April 11, 2024


10:00 AM - 5:00 PM - Antidote Institute

11:30 AM - 1:30 PM - MTF Board Meeting

3:30 - 5:00 PM - Corporate Advisory Council


Friday, April 12, 2024


6:45 - 7:45 AM - Medication Management Section

7:15 - 7:45 AM - Pediatric Section

12:00 - 12:30 PM - Research Committee

12:00 - 1:00 PM - Addiction Toxicology Committee

12:00 - 1:00 PM - Association of Medical Toxicology Division Chiefs and Section Leaders

12:00 - 1:00 PM - Joint Enviro/Occ Med and Govt/Public Health Speaker Session | "Contaminated Applesauce Pouches"

3:30 - 4:30 PM - Military Section

3:30 - 5:00 PM - FiT Activity | "Double Dare"

3:30 - 5:00 PM - ToxIC Meeting


Saturday, April 13, 2024


7:00 AM - 8:00 AM - Resident and Medical Student Section

11:30 AM - 1:00 PM - JMT Editorial Board Meeting

12:00 - 1:00 PM - ACMT Fellowship Directors Committee

12:00 - 1:00 PM - Education Committee

1:00 - 2:00 PM - R25 Advisory Committee

3:30 - 5:00 PM - WiT Speaker Session | "Just Say NO!" with Kathy Grosso, Associate Certified Coach (ACC)


Sunday, April 14, 2024


7:00 - 8:00 AM - International Section

7:00 - 8:00 AM - Toxinology Section


Hassan Al Balushi, MD, OMSB-EM

Emergency Medicine Consultant and Medical Toxicologist

Suhar Hospital, Minitry of Health

Dr. Hassan is an Emergency Medicne Consultant and Medical Toxicologist From Oman, Completed his Medical Degree at Sultan Qaboos University Medical School in Oman in 2013. Completed his Emergency Residency Program and Board at Oman Medical Specialty Board (OMSB), Oman. Completed a 2 year fellowship program in Medical Toxicology at Emory University, Georgea, USA. Dr. Al Balushi is an active member of Middle East and North Africa Medical Toxicology Association (MENATOX), as well as a board member and the secretary of Oman Society of Emergency Medicine (OSEM).

Noah Berland, MD, MS

Assistant Division Director Medical Toxicology

Kings County Hospital

Dr. Noah Berland is an emergency physician and assistant division director of medical toxicology at NYC H+H Kings County Hospital Center. Prior to studying Medicine Dr. Berland obtained a Bachelors and Masters in Electrical Engineering. Dr. Berland obtained his MD from NYU School of Medicine and completed his Emergency Medicine Residency at SUNY Downstate - Kings County Hospital. Dr. Berland went on to complete his Medical Toxicology Fellowship and Rutgers NJMS in Newark NJ.

Elizabeth Boyle, MPH, CIH

Senior Program Officer, Board on Population Health and Public Health Practice

National Academies of Sciences, Engineering, and Medicine

Elizabeth Barksdale Boyle is a Senior Program Officer in the Health and Medicine Division’s Board on Population Health and Public Health Practice after serving for several years as a Program Officer with the Board on Environmental Studies and Toxicology. Formerly, she was an Environmental Health scientist at Westat, where she supported the Environmental Protection Agency, the National Institute of Child Health and Development, and the National Cancer Institute. Before her tenure at Westat, Ms. Boyle was a Student Epidemiologist at the Minnesota Department of Health and an Industrial Hygienist at a consulting firm in Cincinnati. She is a Fellow of the Bloomberg American Health Initiative at the Johns Hopkins Bloomberg School of Public Health, where she is pursuing a Doctor of Public Health in environmental health. Ms. Boyle has an MPH in environmental health from the University of Minnesota, a certificate in risk sciences and public policy from Johns Hopkins University Bloomberg School of Public Health and is a Certified Industrial Hygienist.

Albert Burgess-Hull, PhD

Head Data Scientist, SUDx/MATClinics

University of Maryland

Albert Burgess-Hull is a Data Scientist and Machine Learning Researcher at MATClinics, an outpatient addiction treatment center in Maryland that specializes in Opioid Addiction Treatment. He received his PhD from the University of Wisconsin - Madison and completed postdoctoral fellowship training at the National Institute on Drug Abuse’s Intramural Research Program. Albert’s research focuses on the development and validation of digital diagnostic and prognostic frameworks for the classification and prediction of treatment related outcomes in addiction medicine. He is also interested in how the use of advanced clustering/segmentation methodologies can be used for the development of precision medicine frameworks to deliver the optimal treatment to the right patient at the right time.

Keith Burkhart, MD

Senior Advisor for Medical Toxicology

US Department of Health and Human Services

Senior Advisor for Medical Toxicology in the Division of Applied Regulatory Science in the Office of Clinical Pharmacology in the Office of Translational Science in the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA). He received his medical toxicology training at the Rocky Mountain Poison Center in Denver (1988-1990). Emergency Medicine training was at the University of Cincinnati (1982-1985, Chief Resident). His Medical Degree (1982) is from the Medical College of Pennsylvania, now Drexel University. His B.S. (1978) is from Ursinus College in Biology (valedictorian). He is a Past-President and Fellow of the American College of Medical Toxicology. He is a co-editor of Critical Care Toxicology. He is the former Medical Director of the Penn State Poison Center (1990-2002) associated with an inpatient toxicology admitting service. Research interests include antidotes and treatment of the poisoned patients. At the FDA he started a biological plausibility consult service that would analyze for potential mechanisms as supportive evidence for an emerging drug safety signal. Bioinformatic tools were evaluated and studied to support these analyses. Research has also been done to predict adverse events. He currently is the Medical Monitor for FDA sponsored clinical trials performed to inform regulatory decision making.

Betty Shuk Han Chan, MBBS, PhD

Associate Professor

Prince of Wales Hospital

A/Prof Betty Chan is a clinical toxicologist and emergency physician with major interests in cardiovascular drug poisonings, antidotes and cognitive function following poisoning. She is an Associate Professor with the University of New South Wales – Head of the Discipline of Critical Care, a consultant with the NSW Poisons Information Centre and an associate Editor of the journal Clinical Toxicology. She is an emergency physician, head of the Clinical Toxicology unit at Prince of Wales Hospital, South Eastern Area Toxicology Service (SEATS). Her research findings have led to a change of clinical guidelines in the use of digoxin-Fab in acute and chronic digoxin poisonings, folinic acid in acute and chronic methotrexate poisoning. She has initiated a number of projects which have provided clinical data for further studies in tapentadol poisoning, the use of haemodialysis for acute and chronic lithium poisoning, digoxin-Fab supply and demand, optimal methods to manage severe tricyclic antidepressant and dihydropyridine poisonings.

Po-Hung (Victor) Chen, MD, PhD

Assistant Professor of Medicine

Johns Hopkins Medicine

Dr. Victor Chen is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine and a practicing transplant hepatologist board eligible in addiction medicine. He received his Doctor of Medicine from Emory University School of Medicine before completing an Internal Medicine residency at Duke University Medical Center and successive Gastroenterology and Transplant Hepatology fellowships at the Johns Hopkins Hospital. He also received a Doctor of Philosophy in Clinical Investigation and a certificate in Public Health Economics from the Johns Hopkins Bloomberg School of Public Health. Dr. Chen serves on the Practice Guidelines Committee of the American Association for the Study of Liver Diseases, where he also recently completed his term on the steering committee of the Alcohol Associated Liver Disease Special Interest Group. Additionally, he is a GRADE Methodologist for the American College of Gastroenterology. Dr. Chen is supported by K23 and P50 grants from the NIH/NIAAA for his research on the intersection between alcohol use disorder, alcohol associated liver disease, and liver transplantation. The works of Dr. Chen and colleagues have stimulated nationwide conversations to revise the transplant practice paradigm for patients with alcohol associated liver disease.

Joseph Cocciardi, PhD, MS, FAIHA, CIH, CSP, REHS/RS

Senior Health & Safety Professional

Cocciardi and Associates, Inc

Joseph A. Cocciardi, PhD, MS, CSP, CIH, REHS/RS, has practiced professionally and held academic and instructional positions for more than 35 years. Dr. Cocciardi's breadth of education, experience, and professional certifications have served the public, industrial and commercial sectors in the health, safety, emergency response and environmental protection disciplines.

This service has included the development, management and evaluation of public and occupational health/safety programs, including those with an environmental protection emphasis. Epidemiological study, research and investigation have been conducted over the 35-year period. He has been the Principal Investigator/Project Manager on key environmental protection programs dealing with highly hazardous chemicals and toxic materials and performed multiple hazard and risk assessments in this area. He has also evaluated current and proposed safety and environmental technologies and legislation. 

He holds instructional licenses for work with specialized toxic materials (Asbestos Containing Materials; Lead) and was instrumental in the development of the first EPA licensed training site and public employee education center for the removal of Asbestos Containing Materials within the Commonwealth of Pennsylvania. He assisted with the establishment of a similar public lead poison prevention training center for the Pennsylvania Department of Health/US EPA. He has developed and taught safety and environmental protection programs and seminars at the collegiate level.

In addition to consulting activities, Dr. Cocciardi remains an employee of the U.S. Department of Health and Human Services (HHS), and is designated a TYPE 1 Safety Officer assigned to the HHS Incident Response Coordination Team (IRCT), with both response and planning responsibilities for large scale disaster events. He has deployed nationally and internationally as a member of the Type I HHS Incident Response Coordination Team (IRCT).

Jon Cole, MD, FACMT

Emergency Physician and Medical Toxicologist, Medical Director

Hennepin County Medical Center & Minnesota Poison Control System

Jon Cole is a medical toxicologist and emergency physician at Hennepin Healthcare in Minneapolis, Minnesota. He is Professor of Emergency Medicine at the University of Minnesota Medical School and has been Medical Director of the Minnesota Poison Control System since 2011. He has published extensively in emergency medicine and toxicology, focusing on emergency pharmacology, management of drug-induced shock and delirium, and care of patients with substance use disorders in the emergency department.

Vinodinee L. Dissanayake, MD, MPH

Assistant Professor, Department of Emergency Medicine

Rush University Medical Center

Dr. Dissanayake received her medical degree from Keck School of Medicine at the University of Southern California, Los Angeles, CA. She completed her Emergency Medicine residency at Cook County Hospital in Chicago, IL, and her Global Toxicology fellowship at the University of Illinois. Her areas of expertise and interest are Global Health, Social Emergency Medicine, and Medical Toxicology. 

John Downs, MD, MPH

Associate Professor and Associate Program Director

Occupational & Environmental Medicine Residency, Uniformed Services University

John W. Downs, MD, MPH is a graduate of the Virginia Military Institute and served two years as a US Army infantry officer, prior to attending medical school at the Uniformed Services University of the Health Sciences (USU). Dr. Downs completed residency training in internal medicine at Tripler Army Medical Center, Honolulu, Hawaii, and in occupational & environmental medicine at USU, where he also completed a Master of Public Health (MPH) degree.  Dr. Downs later completed fellowship in medical toxicology at the Virginia Commonwealth University Health System-Medical College of Virginia. Dr. Downs is currently stationed at the Uniformed Services University where he is an Associate Professor and the Associate Program Director for the occupational and environmental medicine residency, and an attending physician at Walter Reed National Military Medical Center.  Dr. Downs is board certified in internal medicine, occupational medicine, and medical toxicology, and is a certified public health professional (CPH).  He is a Fellow of the American College of Physicians, and the American College of Occupational and Environmental Medicine. 

Carla Foster, MPH

Epidemiologist and Principal Investigator

New York City Department of Health and Mental Hygiene

Carla Foster is an Epidemiologist and Principal Investigator at the New York City Department of Health and Mental Hygiene (NYC DOHMH) in the Health Care Provider Initiatives Unit. Her research focuses on the implementation and evaluation of public health detailing campaigns across New York City with the aim of improving clinical decision making and advancing a culture of health. Her research interests include implementation science and the impact of bias, racism, and white supremacy culture on physical and mental health. During DOHMH’s Incident Command System COVID-19 emergency activation response she served as Deputy Director of the Integrated Data Team. Prior to joining the NYC DOHMH, she led development of clinical practice guidelines at the American Urological Association. She obtained dual Bachelor of Arts degrees in Pan-African Studies and Neuroscience from Wellesley College. Carla obtained her Master of Public Health Degree in Epidemiology from Columbia University where she is also currently pursuing a doctorate in Epidemiology.

Albert Garcia-Romeu, PhD

Associate Professor, Behavioral Pharmacology Research Unit

Johns Hopkins University

Albert Garcia-Romeu, Ph.D. is an Associate Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. His research examines the effects of psychedelics in humans, with a focus on psilocybin as an aid in the treatment of addiction. His current research interests include clinical applications of psychedelics, real-world drug use patterns, diversity in science, and the role of spirituality in mental health. He is a founding member of the Johns Hopkins Center for Psychedelic and Consciousness Research and the International Society for Research on Psychedelics. He serves on the Board of Directors for the College on Problems of Drug Dependence (CPDD) and is an Associate Editor for the journal Psychedelic Medicine.

Richard Hamilton, MD, MBA, FACMT, FACEP, FAAEM

Professor and Chair of Emergency Medicine

Drexel University College of Medicine

Dr. Hamilton is Professor and Chair, Emergency Medicine, Drexel University College of Medicine. He is the Chief Academic Officer, DIO, and Regional Associate Dean for the Crozer Keystone Campus and EM System Chair of the Crozer Keystone Health System. Dr. Hamilton's research interests include PFAS and Manganese drinking water standards. He has received awards for his teaching and research and is a widely published author of manuscripts, textbooks, and book chapters, and patents.

Michael G. Holland, MD, FEAPCCT, FAACT, FACOEM, FACMT, FACEP

Professor of Emergency Medicine

SUNY Upstate Medical University

Dr. Holland is Clinical Professor of Emergency Medicine at SUNY Upstate Medical University in Syracuse, NY where he is on the faculty of the Medical Toxicology Fellowship Training Program and is a Consulting Medical Toxicologist at the Upstate New York Poison Center and the Onondaga County Medical Examiner’s Office-both in Syracuse, NY. Dr. Holland is also the Director of Occupational Medicine for the Saratoga Hospital Medical Group, and is the Saratoga Hospital Employee Health Medical Director, where he oversees the health and safety of over 3100 employees and staff. He also serves as Employee Health Medical Director at Glens Falls Hospital in Glens Falls, NY, covering 2500 employees. He is also Principal Medical Toxicologist at the Center for Toxicology and Environmental Health (CTEH) in Little Rock, AR.    

Geoff Isbister, MD

Professor, School of Medicine and Public Health

University of Newcastle

I am a Professor and NHMRC Senior Research Fellow at the University of Newcastle. I am a consultant clinical toxicologist and emergency physician, Director of the Department of Clinical Toxicology, Calvary Mater Hospital and consultant toxicologist to the NSW Poisons Information Centre. I was made a Member of the Order of Australia in 2019 for my contribution to toxicology. I am President Elect of the Asia Pacific Assocation of Medical Toxicologists. My major area of research is snake bite. I have published over 375 papers and received $20 million in research funds.

David Jang, MD, MSc, FACMT

Assistant Professor

University of Pennsylvania School of Medicine

We are interested in studying the interaction of mitochondrial function in the area of acute care that includes sepsis and acute poisoning. We are currently taking a translational approach studying the mitochondria at a cell-based level, to various animal models, all the way to the clinical setting actively enrolling patients with these acute medical conditions with the goal to develop better prognostic measures with the potential for mitochondrial-directed therapy. 

Our lab has the latest models of the O2k-FluoRespirometer (O2k-Series H), Western blotting, confocal microscopy to study mitochondrial function in both in vitro and in vivo models with a focus on mitochondrial-directed therapies using substrate prodrugs. Relevant in vivo platforms include zebrafish, murine and porcine models of acute critical care illnesses that also combine state of the art physiological monitoring such as PV loop catheters providing realtime physiological data to be linked with cellular function. Our other interests also utilize the use of blood cells as proxy of organ cellular function as a type of biomarker which may provide prognostic function and allow clinicians to better gauge response to therapy. 

Combining these elements we aim to better understand the complex interactions of both bioenergetics in issues of acute care to better improve patient care and outcomes.

Emily Kiernan, DO

Assistant Professor of Emergency Medicine and Medical Toxicology

Emory University School of Medicine

Dr. Kiernan is an Assistant Professor at Emory University School of Medicine. She is a board-certified Emergency Medicine physician who recently completed a medical toxicology fellowship at Emory University/CDC. She has served as the fellow co-chair for the AACT Radiation Special Interest Section group as well as a chair in the ACMT Fellow-in-training association.

Mark Kirk, MD

Senior Advisor, Chemical Defense, DHS Countering Weapons of Mass Destruction

Department of Homeland Security

Mark A. Kirk, MD serves as Senior Advisor for Chemical Defense in the Department of Homeland Security's Office of Countering Weapons of Mass Destruction, addressing chemical security and chemical defense matters at the Federal government and local jurisdictional level. He began supporting DHS chemical defense efforts in 2008.  He is an emergency physician and medical toxicologist with special interests in critical care toxicology, mass gathering preparedness, and incident response to large-scale hazardous materials incidents and chemical terrorism. 

Kathryn Kopec, DO, FACMT

Associate Professor, Division Director of Medical Toxicology

Carolinas Medical Center

Dr. Kathryn Kopec is currently an Associate Professor of Emergency Medicine and the Director of the Medical Toxicology Division at Carolinas Medical Center in Charlotte, NC. Dr. Kopec obtained her bachelor's degree in biology from the University of Dayton and her medical degree from Michigan State College of Osteopathic Medicine. She completed her Emergency Medicine residency and Medical Toxicology fellowship at Einstein Medical Center in Philadelphia, PA. She is currently on the ACMT Board of Directors. Academically her interests involved global toxicology, drugs of abuse, agitated delirium and toxicology education.

Michael J. Kosnett, MD, MPH, FACMT

Associate Clinical Professor, Department of Medicine

University of Colorado School of Medicine

Michael J. Kosnett, MD, MPH, FACMT has 34 years of experience as a physician specializing in medical toxicology and occupational and environmental health. He is board certified in internal medicine, medical toxicology, and preventive medicine (occupational medicine). He has served in a leadership and advisory capacity to multiple national and international medical and public health organizations. This includes service as past president of the American College of Medical Toxicology and a member of the Committee on Toxicology of the National Academies of Sciences, Engineering, and Medicine and the Board of Scientific Counselors of the National Institute for Occupational Safety and Health. In addition, Dr. Kosnett has served as a consultant and temporary advisor to the World Health Organization; EPA Science Advisory Board expert panels; and advisory committees of the CDC National Center for Environmental Health and ATSDR. He has also served as a medical toxicology consultant to the US Army Public Health Command, the US Air Force Science Advisory Board, and the US Navy Naval Air Systems Command. In 2016, the American College of Medical Toxicology awarded Dr. Kosnett the Matthew J. Ellenhorn Award, a career achievement award that recognizes “extraordinary contributions to the field of medical toxicology.”

JoAn Laes, MD, DFASAM, FACMT

Addiction Staff Physician

Abbott Northwestern Hospital, Allina Health

JoAn Laes, MD, DFASAM, FACMT is an addiction medicine physician in Minneapolis, Minnesota, focusing on inpatient addiction medicine and toxicology consultation as well as experience in outpatient treatment of opioid and other substance use disorders. She is also a core medical toxicology faculty for the Minnesota Poison Center, Minneapolis, Minnesota, and medical director for Missions Inc. Detox facility in Plymouth, Minnesota. She is board certified in Internal Medicine, Medical Toxicology, and Addiction Medicine. She completed internal medicine residency at Hennepin County Medical Center and medical toxicology fellowship at Regions Hospital in St. Paul, Minnesota.

Jeffrey Lai, MD

Assistant Professor of Emergency Medicine

UMass Memorial

Jeffrey Lai, MD, is an emergency physician and medical toxicologist at UMass Chan Medical School and UMass Memorial Health. He is the medical toxicology fellowship director and the clerkship director for the Introduction to Medical Toxicology elective at UMass Chan Medical School. His academic interests include medical education, the application of novel technologies to the treatment of substance use disorder, and the surveillance of impairing substances in patients with severe traumatic injuries.

Ophir Lavon, MD, FEAPCCT

Head, Clinical Pharmacology and Toxicology Unit & Chair

Carmel Medical Center & Israel Society of Toxicology

Ophir Lavon is a Doctor of Medicine (MD) at the Rappaport Faculty of Medicine, Technion–Israel Institute of Technology. He is a Board-Certified Expert in Internal Medicine, Clinical Pharmacology and Toxicology. Dr. Lavon is the current chair of the Israel Society of Toxicology. He is a Fellow and a board member of the European Association of Poisons Centres and Clinical Toxicologists. He is heading the Clinical Pharmacology and Toxicology Unit, Carmel Medical Center in Haifa, Israel. Dr. Lavon is a Clinical Senior Lecturer at the Rappaport Faculty of Medicine. He also serves as the Chair of the National Antidote Stockpiling Committee. He is a board member of the Israel Association for Clinical Pharmacology, and a member of the American College of Medical Toxicology. He is the Former Head of the Patient Safety and Risk Management Unit, Carmel Medical Center in Haifa, Israel.

Brian Linde, MD, MPH

Associate Program Director, Chief of Occupational Health Services

Yale Occupational and Environmental Medicine Program (YOEMP) & VA Connecticut Healthcare System (VACHS)

Brian Linde is the Chief of Occupational Health Services at VA Palo Alto Healthcare System (VAPAHCS) and faculty physician at Stanford Workforce Health and Wellness. Prior to joining VAPAHCS and Stanford Health Care last year, Dr. Linde was Associate Program Director of the Yale Occupational and Environmental Medicine Program (YOEMP) and Chief of Occupational Health Services at the VA Connecticut Healthcare System (VACHS). As Associate Program Director of YOEMP, he oversaw the medical education and training for the physicians in training in Occupational and Environmental Medicine. He has also designed curricula to train Internal Medicine residents in core aspects of Occupational and Environmental Medicine. As Chief of Occupational Health Services at VAPAHCS, he oversees the Medical Center Occupational Health Services for over 5,000 employees in the VA Palo Alto Healthcare System. Services include medical surveillance, work injury evaluation and management, infection prevention, and employee health and well-being. As a Board Certified Occupational and Environmental physician, he also provides patient consultations to evaluate health effects of occupational and environmental exposures. Dr. Linde received his M.P.H. in Occupational and Environmental Medicine from Yale School of Public Health, and his M.D. from Albert Einstein College of Medicine, Yeshiva University.

Kevin F. Maskell, Jr., MD

Assistant Professor of Military and Emergency Medicine

Brooke Army Medical Center

Dr. Maskell is board certified in emergency medicine, medical toxicology, and addiction medicine.  He has an appointment as Assistant Professor of Military and Emergency Medicine at Uniformed Services University of Health Sciences and currently serves as the Medical Director of the Tactical Medicine Readiness Division at the US Army Medical Department Medical Center of Excellence, Ft. Sam Houston, Texas.  He also serves as guest faculty at Brooke Army Medical Center and as a Consulting Toxicologist for the Washington Poison Center.  He graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science, completed his Emergency Medicine residency at Madigan Army Medical Center in Tacoma, Washington, and his Medical Toxicology fellowship at Virginia Commonwealth University in Richmond, Virginia.  

Dan McCabe, MD

Clinical Associate Professor & Director, Division of Medical Toxicology

University of Iowa Hospitals & Clinics, Iowa Poison Control Center

Dr. Dan McCabe is a medical toxicologist and emergency medicine physician at the University of Iowa Hospitals & Clinics, as well as a Clinical Associate Professor of Emergency Medicine at the University of Iowa, the Director of the Division of Medical Toxicology at the University of Iowa, and the Medical Director of the Iowa Poison Control Center. Dr. McCabe received his medical degree from the University of Iowa. He completed a residency in emergency medicine at Cook County Hospital and a fellowship in medical toxicology at the Regions Hospital/Minnesota Poison Control System. Dr. McCabe has a broad range of interests including improvement of care for the poisoned patient, toxicology, addiction medicine, resource utilization, and public health.

Sean D. McCann, MD

Assistant Professor of Clinical Emergency Medicine and Medical Toxicology

University of Illinois Chicago

Sean McCann is an Assistant Professor of Clinical Emergency Medicine and Medical Toxicology at the University of Illinois at Chicago (UIC). He completed undergraduate studies in neuroscience, as well as medical school at the University of Pittsburgh. He then completed emergency medicine residency at Resurrection Medical Center in Chicago, Illinois. After residency he received fellowship training in medical toxicology at the Toxikon Consortium, a joint program through UIC, Cook County Health and the Illinois Poison Center. 

His fellowship research included projects addressing severe unintentional carbon monoxide poisoning, the impact of FDA packaging guidelines on loperamide abuse and misuse, severe methemoglobinemia secondary to sodium nitrite poisoning. Since completing fellowship in 2020, Dr. McCann has served as emergency medicine and medical toxicology faculty at UIC. In addition to working clinically in the Emergency Department, he sees patients on the inpatient toxicology consult service, takes medical backup call for the Illinois Poison Center, and helped establish an outpatient medical toxicology clinic. His current research focuses on lead poisoning in refugee and emergency department patient populations.

Charles McKay, MD, FACMT

Associate Medical Director

CT Poison Control Center, University of Connecticut School of Medicine

Dr. McKay was trained in Anatomic and Surgical Pathology, Internal Medicine, Emergency Medicine, Medical Toxicology and was a Medical Director of Occupational Health and Medical Review Officer for a hospital system during more than 30 years of clinical practice, during which he provided toxicology consultation at 3 hospitals, directed a medical toxicology fellowship training program, and provided medical oversight of a regional poison control center. He provides medical legal consultation across the country on toxicology-related issues, and has testified in nearly 100 cases, many related to questions of alcohol- and -drug-induced impairment.

Elisabeth Moore, DO

Assistant Professor of Clinical Emergency Medicine

Weill Cornell Medicine

Dr. Moore is currently an Assistant Professor of Clinical Emergency Medicine and Medical Toxicology at Weill Cornell Medicine in New York City.  She completed her Emergency Medicine Residency training at Lehigh Valley Health Network in and her Fellowship in Medical Toxicology at Banner-University Medical Center in Phoenix. She is actively involved in Women in Toxicology (WiT), and helps to produce the  “Tox in Ten” and “ ACMT Highlights” Podcast.

Mark Mycyk, MD, FACMT

Chair of Research

Cook County Health

Dr. Mycyk currently serves as the Chair of Research for the Department of Emergency Medicine at Cook County Health. He is a board member of several biomedical journals, including service as Editor-in-Chief of Journal of Medical Toxicology and Associate Editor of Academic Emergency Medicine. Dr. Mycyk received an AB in English and American Literature and Language from Harvard College and an MD from University of Illinois. He completed his Residency in Emergency Medicine at Boston City Hospital/Boston Medical Center and his fellowship at Toxikon Consortium.

Nicholas Nacca, MD

Assistant Professor of Emergency Medicine, Director of Medical Toxicology, Associate Fellowship Director of Medical Toxicology Fellowship Program

University of Rochester Medical Center

Dr. Nacca is the director of Medical toxicology and Associate Fellowship Director at the University of Rochester Medical Center. In addition to being faculty member in the Department of Emergency Medicine he holds a secondary appointment in the Department of Environmental Medicine. His primary role is staffing the educational and clinical medical toxicology consultation service, with educational responsibilities to medical toxicology fellows, multidisciplinary teams of medical residents, pharmacy residents and students, as well as medical students. He staffs and directs a referral based outpatient Medical Toxicology Clinic.

Antonia Nemanich, MD

Assistant Professor

Rush University

Dr. Antonia Nemanich is an assistant professor of emergency medicine, medical toxicology and addiction medicine at Rush University Medical Center in Chicago. She recently graduated from the Toxikon Consortium fellowship in Chicago and now continues to be involved with the fellowship as faculty.

Jenna Nikolaides, MD, MA, FACEP

Assistant Professor, Department of Emergency Medicine

Rush University Medical Center

Dr. Nikolaides is an Assistant Professor in the Department of Emergency Medicine with a dual appointment in the Department of Psychiatry at Rush University Medical Center.  She is board certified in Emergency Medicine, Medical Toxicology and Addiction Medicine.  She is a graduate of Northwestern Medical School, getting both her MD and a Masters in Medical Humanities and Bioethics.  She completed her residency in Emergency Medicine at SUNY Buffalo and her fellowship in Medical Toxicology at University of Illinois / Cook County Hospital.  She completed an additional International Research Fellowship in Toxicology at the University of Edinburgh in Scotland prior to joining Rush. She now serves as the Director of Medical Toxicology, and the Director of Rush’s Substance Use Intervention Team.

Daniel Nogee, MD, MHS

Chief of Consultation, Chemical Casualty Care Division

U.S. Army Medical Research Institute of Chemical Defense

Dr. Daniel Nogee is a board-certified medical toxicologist and emergency medicine physician currently serving as the Chief of Consultation within the Chemical Casualty Care Division (CCCD) of the United States Army Medical Research Institute of Chemical Defense (USAMRICD). Dr. Nogee earned his medical degree from the Johns Hopkins University School of Medicine. While in medical school, he completed a research year at the National Institute of Allergy and Infectious Diseases at the National Institutes of Health campus in Bethesda, MD through the Medical Research Scholars Program. Dr. Nogee completed internship and residency in emergency medicine at Yale-New Haven Hospital, and completed a Masters in Health Sciences through the Yale University School of Medicine as well as a research fellowship in emergency medicine as part of the Yale Emergency Scholars program. Dr. Nogee completed fellowship training in Medical Toxicology through the Emory University School of Medicine-Centers for Disease Control and Prevention (CDC) Medical Toxicology Fellowship in Atlanta, GA. While serving as a medical officer for the CDC’s National Center for Environmental Health he was deployed as a field investigator for an outbreak of non-viral hepatitis in the Las Vegas area.

During medical school, Dr. Nogee commissioned as an officer in the United States Army/Maryland Army National Guard. He is currently assigned as a Field Surgeon with the 224th Medical Company (Area Support) in Olney, MD. During 2020 he deployed in support of COVID-19 response efforts in Maryland. In 2021, he deployed to the Middle East as a Battalion Surgeon with the 29th Infantry Division Headquarters and Headquarters Battalion. 

Anthony Pizon, MD, FACMT

Chief of Medical Toxicology Division, Professor of Emergency Medicine

University of Pittsburgh

Dr. Anthony (Tony) Pizon received his medical degree from the University of Toledo School of Medicine in 2001.  He then completed his Emergency Medicine Residency at the University of Pittsburgh Medical Center in 2004 and his Medical Toxicology Fellowship at Banner Good Samaritan Medical Center in Phoenix, Arizona in 2006. Dr. Pizon is currently a Professor in the Department of Emergency Medicine, Division of Medical Toxicology at the University of Pittsburgh, School of Medicine. He serves as Chief of the Division of Medical Toxicology and Director of the Medical Toxicology Fellowship at UPMC. He is also Assistant Medical Director of both the Pittsburgh and West Virginia Poison Centers. Yet, most importantly, he is blessed with amazing wife, Caryn, and four wonderful children (Benjamin, Elizabeth, Gabriela, and Seraphina).

Jorge Guillermo Perez Tuñon, MD

Head of Clinical Toxicology Service & Certified Pediatrician

Angeles Lomas Hospital

Dr. Pérez Tuñón currently holds the position of Chief at the Centro Toxicológico del Hospital Angeles Lomas (Poison Control Center at Angeles Lomas Hospital) and serves as the Head Professor of Clinical Toxicology at the Universidad Nacional Autónoma de México (National Autonomous University of Mexico). He is a certified Pediatrician and holds a Master degree on Pharmacology. Dr. Pérez Tuñón has been professor for over 12 years and participated on more of 30 publications. Finally, he is blessed with a loving wife, Sandra, and three incredible children.

Robert Cole Pueringer, MD

Medical Toxicologist and Addiction Medicine Specialist

Essentia Health

Dr. Robert “Cole” Pueringer is a Medical Toxicologist, Addiction Medicine Specialist, and Hospitalist. He joined Essentia Health in September of 2022. He completed his medical training in the Twin Cities, including Medical School at the University of Minnesota, Internal Medicine Residency and Chief Resident year at Hennepin County Medical Center (HCMC). He received his CTropMed certification for Tropical Medicine & Travelers’ Health at the University of Minnesota. He then completed a Medical Toxicology fellowship at the Health Partners Institute/HCMC in 2021 and an Addiction Medicine fellowship at the University of Minnesota in 2022. His academic interests include medical education, Global Health, and the overlap of Medical Toxicology and Addiction Medicine. He is particularly passionate about substance use disorder - a disease that has affected many aspects of his own life – and hopes to contribute significantly to substance use treatment, education, de-stigmatization, and harm reduction in northern Minnesota.

Mindy Richlen, PhD

Research Specialist, Biology

Woods Hole Oceanographic Institution

Dr. Mindy Richlen is a Senior Research Specialist at the Woods Hole Oceanographic Institution, specializing in harmful algal blooms (HABs) and Oceans and Human Health (OHH). Her expertise encompasses field and laboratory studies on the ecology, diversity, and molecular biology of HABs. As Project Lead for the Woods Hole Center for Oceans and Human Health (WHCOHH) Community Engagement Core (CEC), Dr. Richlen focuses on fostering collaboration with stakeholder and public health communities. She is also dedicated to community and classroom outreach, having developed K-12 activities based on WHCOHH research. In the national HAB community, Dr. Richlen serves as the Assistant Director of the U.S. National Office for Harmful Algal Blooms. This office, established by the National Oceanographic and Atmospheric Administration, aims to improve engagement and coordination within the HAB research and management community, industry, and the public. Dr. Richlen brings a wealth of experience and a versatile skill set to her work. She is well-versed in planning, executing, and publishing research on HABs, translating findings, and effectively engaging diverse audiences in OHH research.

Joshua Shulman, MD

Medical Director

Pittsburgh Poison Center

Dr. Joshua Shulman is the Medical Director of the Pittsburgh Poison Center. He completed his undergraduate Summa Cum Laude at the University of Pittsburgh with a Bachelor of Arts and a Bachelor of Sciences (B.A./B.S.) in History and Neuroscience. He completed his Medical Doctorate (MD) degree at the University of Pittsburgh School of Medicine in 2012. He trained as a resident physician at UPMC Medical Education in Emergency Medicine from 2012 to 2015, and as a fellow in Medical Toxicology between 2015 and 2017. He was appointed a position of Assistant Professor of Emergency Medicine and Medical Toxicology at the University of Pittsburgh School of Medicine. He also holds an appointment as an Assistant Professor of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy. He is a diplomate of the American Board of Emergency Medicine, American Board of Medical Toxicology, and the American Board of Preventative Medicine in Addiction Medicine. He is currently practicing in UPMC Hospitals in the fields of Emergency Medicine, Medical Toxicology and Addiction Medicine.

Hannah Spungen, MD, MPH

Toxicology Fellow

Banner University Medical Center-Phoenix

Dr. Spungen is a second year Medical Toxicology fellow at Banner—University Medical Center Phoenix. She completed her Emergency Medicine residency at UCLA Ronald Reagan/Olive View. Her research interests include bias and spin in scientific communication, vasopressor dosing in cardiodepressant drug toxicity, and using R to explore large toxicologic data sets. 

Trevonne Thompson, MD

Professor of Emergency Medicine & Medical Toxicology

University of Illinois College of Medicine/Toxikon Consortium

Dr. Trevonne M. Thompson is an attending emergency physician and medical toxicologist at UI Health and a tenured professor of Emergency Medicine and Medical Toxicology at the University of Illinois College of Medicine (UICOM). He obtained his undergraduate degree from Xavier University of Louisiana in New Orleans. After graduating with a degree in Biology and minors in Chemistry and Spanish, he attended medical school at the Feinberg School of Medicine at Northwestern University in Chicago. He served his emergency medicine residency at Cook County Hospital (now Stroger Hospital of Cook County). After serving as Chief Resident in Emergency Medicine, he completed a Medical Toxicology fellowship at the Toxikon Consortium in Chicago. Dr. Thompson is the head of the Division of Medical Toxicology within the Department of Emergency Medicine at UICOM. He leads the medical toxicology consultation service and clinic at UI Health. He is a consultant to the Illinois Poison Center and is an associate program director for the Toxikon Consortium Medical Toxicology Fellowship.

Dr. Thompson is the Associate Dean for Admissions for the University of Illinois College of Medicine. He is a past chair of the Emergency Medicine Section of the National Medical Association.

Michael Toce, MD, MS

Assistant Professor of Pediatric and Emergency Medicine

Harvard Medical School

Dr. Michael Toce completed his undergraduate studies at Carleton College where he received a B.A. in biology and biochemistry. He received a M.S. in bacteriology from the University of Wisconsin-Madison, and his M.D. from the Medical College of Wisconsin. He completed his pediatrics residency at the Boston Combined Residency Program before completing a Medical Toxicology Fellowship and Pediatric Emergency Medicine Fellowship at Boston Children's Hospital. He is currently an attending in the Boston Children's Hospital Emergency Department and works as a Medical Toxicologist at the MA/RI Poison Control Center. Dr. Michael Toce conducts research that focuses on pediatric toxicology and emergency medicine. He has published on the association of state opioid reduction policies with pediatric opioid poisonings and is currently focused on assessing the association of naloxone access laws and adolescent and young adult opioid overdose.

Michael J. Twiner, MD, PhD

Assistant Professor, Department of Emergency Medicine

Wayne State University

Dr. Twiner has studied environmental toxicology for over 20 years earning his PhD from Western University (Ontario, Canada). The main focus of his early research career involved identifying and characterizing the toxicological mechanisms of marine and freshwater algal toxins with applications towards the development of molecular and biochemical detection methods as well as assessing the health effects of these toxins on marine mammals and humans. He spent several years working at the National Oceanic and Atmospheric Administration’s Center for Coastal Environmental Health and Biomolecular Research in Charleston, SC before developing his own research laboratory at the University of Michigan. He continued to carry on his research program while completing his medical degree and then residency in Emergency Medicine at Detroit Receiving Hospital, Detroit, MI USA. He is now an attending physician at Detroit Medical Center, Detroit, Michigan.  He holds an academic position with Wayne State University where he continues his algal toxin research but has also branched out to work on research projects involving hypertension and heart failure in the underserved communities within and around Detroit. To date, he has published over 40 research papers. 

Nora D. Volkow, MD

Director, National Institute on Drug Abuse (NIDA)

National Institutes of Health (NIH)

Nora D. Volkow, M.D., is Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. NIDA is the world’s largest funder of scientific research on the health aspects of drug use and addiction.

Dr. Volkow's work has been instrumental in demonstrating that drug addiction is a brain disorder. As a research psychiatrist, Dr. Volkow pioneered the use of brain imaging to investigate how substance use affects brain functions. In particular, her studies have documented how changes in the dopamine system affect the functions of brain regions involved with reward and self-control in addiction. She has also made important contributions to the neurobiology of obesity, ADHD, and aging. 

Dr. Volkow was born in Mexico and earned her medical degree from the National University of Mexico in Mexico City, where she received the Robins Award for best medical student of her generation. Her psychiatric residency was at New York University, where she earned a Laughlin Fellowship from The American College of Psychiatrists as one of 10 outstanding psychiatric residents in the United States.

Much of her professional career was spent at the Department of Energy’s Brookhaven National Laboratory in Upton, New York, where she held several leadership positions including Director of Nuclear Medicine, Chairman of the Medical Department, and Associate Laboratory Director for Life Sciences. Dr. Volkow was also a professor in the Department of Psychiatry and Associate Dean of the Medical School at The State University of New York at Stony Brook.

Dr. Volkow has published almost a thousand peer-reviewed articles, written 113 book chapters, manuscripts and articles, co-edited "Neuroscience in the 21st Century" and edited four books on neuroscience and brain imaging for mental and substance use disorders.

She received a Nathan Davis Award for Outstanding Government Service, was a Samuel J. Heyman Service to America Medal (Sammies) finalist and is a member of the National Academy of Sciences and the Association of American Physicians. Dr. Volkow received the International Prize from the French Institute of Health and Medical Research for her pioneering work in brain imaging and addiction science; was awarded the Carnegie Prize in Mind and Brain Sciences from Carnegie Mellon University; and was inducted into the Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) Hall of Fame. She was named one of Time magazine's "Top 100 People Who Shape Our World"; one of "20 People to Watch" by Newsweek magazine; Washingtonian magazine’s "100 Most Powerful Women"; "Innovator of the Year" by U.S. News & World Report; and one of "34 Leaders Who Are Changing Health Care" by Fortune magazine.

Sarah Weiss, MD, MBS

Director of Medical Toxicology

Reading Hospital, Tower Health

Sarah Weiss is a medical toxicologist currently practicing in Reading, Pennsylvania. Her undergraduate education at Hampshire College fueled her ongoing desire for learning and discovery. She returned to her home city of Philadelphia to attend Drexel University College of Medicine. She then went on to Emergency Medicine residency at Stony Brook University Hospital and toxicology fellowship at Einstein Healthcare Network.

Sarah's favorite areas of interest in toxicology are critical poisonings by psychotropic agents and care of people who use drugs. She is particularly interested in the intersections between recreational substance use, self-harm, and mental health. She cares deeply about teaching at all levels of training, from pre-medicine/high school to continuing medical education for practicing providers, as well as community education.  She has given presentations specifically on the care of people who use drugs, LGBTQ+ patients, and done health outreach projects for those communities. She is invested in the care of underserved communities including those with drug dependence, un/underinsured, and those with housing insecurity.

Outside of her professional life, Sarah never quite "grew up" and loves to climb and play. She is a professionally trained trapeze artist and an avid crafter. She particularly loves knitting, crochet, and spinning her own yarn. She shares her Reading home with two humans, a dog, a cat, and three rabbits.

Stephanie Weiss, MD, PhD

Staff Clinician, Translational Addiction Medicine Branch

National Institute on Drug Abuse

Dr. Stephanie Weiss is the Staff Research Physician serving the Translational Addiction Medicine Branch of the National Institute on Drug Abuse’s Intramural Research Program. After earning a Ph.D. in pharmaceutical chemistry, Dr. Weiss received her medical degree in 2011.  She is board certified in emergency medicine, addiction medicine, and medical toxicology and was selected to participate in the Boston University Research in Addiction Medicine Scholars Program prior to joining NIDA.  Dr. Weiss is responsible for providing optimal, safe, and ethical care to study participants and clinical support toward the TAMB mission conducting inpatient and outpatient proof-of-concept human laboratory studies. Her research interests include novel psychoactive substances, medication misuse, and improving interpretation of urine drug testing.

Jason Wheatley, LCSW-C

Lead Clinical Social Worker

Johns Hopkins Comprehensive Transplant Center

Jason has worked with the Comprehensive Transplant Center at Johns Hopkins Hospital for more than a decade, supporting candidates and recipients of solid organ transplants and vascular composite allographs--with a particular focus on liver, kidney, and genitourinary VCAs. He has been a contributing author to published research on Early Liver Transplant for Alcohol-related Liver Disease and has served as guest speaker and content expert on the same subject in multiple national conference presentations as well as educational sessions for various departments within the Johns Hopkins Hospital and other community health organizations. He is a champion of multi-disciplinary health care delivery and regularly advocates for a comprehensive, inclusive, and person-centered approach to transplant care. When he is not working he is likely laughing, crying, or otherwise creating chaos with his spouse and 4 young children.

Timothy Wiegand, MD, DFASAM, FACMT, FAACT

Director of Addiction Medicine and Addiction Medicine Consults

University of Rochester Medical Center

Timothy J. Wiegand, MD, FACMT, FAACT, DFASAM is an Associate Professor of Emergency Medicine and Public Health Sciences at the University of Rochester Medical Center in Rochester New York.  He is Board Certified in Medical Toxicology and Addiction Medicine and practices in Addiction Toxicology with a mix of clinical,  research, teaching, and other professional work.  Dr. Wiegand has served two terms on the Board of Directors for the American College of Medical Toxicology (ACMT) and he is currently serving on the Board of Directors for the American Society of Addiction Medicine (ASAM) completing a term on the Executive Counsel as Vice President of ASAM.  He begins a two-year term as Treasurer of ASAM in April 2023.  Dr. Wiegand founded and led the Toxicology service at URMC until 2022 when he became Director of Addiction Medicine and Director of Addiction Medicine Consults also at URMC in the Department of Emergency Medicine.  Dr. Wiegand has served as Fellowship Director for the URMC Combined Addiction Medicine Fellowship and he is the Fellowship Director for the URMC Medical Toxicology fellowship expecting to formally begin once accredited, in July of 2023.

Mark Lawrence Zammit, B.Pharm (Hons.)

Advanced Pharmacy Practitioner

University of Malta & Ministry for Health, Malta

Mark Lawrence Zammit was born in 1974 and raised in Malta. He is employed as an Advanced Pharmacy Practitioner within the Ministry for Health, Malta and is a Visiting Senior Lecturer within the Department of Clinical Pharmacology and Therapeutics, Faculty of Medicine and Surgery, University of Malta (UOM).

He has expertise in clinical toxicology and pharmacology. He has worked within the Department of Health, Malta for more than 25 years in various positions and been asked to represent Malta in various fora both nationally as well as internationally.

He lectures clinical toxicology and pharmacology at the UOM and has researched the roles and functions of poisons information centers. He has also been involved in international collaborative projects in clinical toxicology. He has extensively lectured at International congresses and developed curricula and training programs in pharmacology and clinical toxicology.

He is a fellow of the European Association of Poisons Centres and Clinical Toxicologists and a member of the American Academy of Clinical Toxicology as well as an Associate Member of the Royal Pharmaceutical Society.

He has been General Secretary of EAPCCT and is an EAPCCT Executive Committee Member. He is also a member of the EU pool of experts on ad hoc rapid risk assessment relating to cross border toxicological risks and a management committee member of the European Venom Network (EUVEN). He also co-authored a number of World Health Organization documents relating to poison centres and clinical toxicology.

Registration Rates

Registration includes:

  • Access to the in-person event on April 12-14, 2024

  • Access to the on-demand recordings (if provided by speaker) for 90 days after the event.

  • Access to the Speaker slides

  • Downloadable Certificate of Attendance
ACMT Member RatesEarly-Bird

Expires: Feb 20, 2024

Regular Rate

Begins: Feb 21, 2024


     Member Tier I: Full, Affiliate, International, Emeritus

$650
$750

     Member Tier II: Fellows

$450
$550

     Member Tier III: Residents, International - Developing Country


$350

$450

     Member IV: Medical Students


$250

$350

Non-Member RatesEarly-Bird

Expires: Feb 20, 2024

Regular Rate

Begins: Feb 21, 2024


     Non-member Tier I: Physicians, Pharmacists, Lawyers, "Other"


$950

$1,050

     Non-member Tier II: Fellows, SPIs, Nurses, etc.


$650

$750

     Non-member Tier III: Educators & Emergency Responders


$550

$650

     Non-member IV: Residents & Students


$450

$550


Early-Bird Rate

Early-bird rates expire at midnight on FEBRUARY 20, 2024. Fees increase to the Regular Rate after this date, no exceptions.


ACMT Membership

ACMT Members receive a discounted rate. Interested in becoming an ACMT Member? Contact our Membership Manager at membership@acmt.net. Learn more at: www.acmt.net/membership


Continuing Education

Continuing Education credit for this activity is available for an additional fee and is provided by AKH Inc., Advancing Knowledge in Healthcare. The activity is accredited for both live and enduring participation for the following:

  • Physicians (Continuing Medical Education)
  • Pharmacists (Continuing Pharmacy Education)
  • Nurses (Continuing Nursing Education)

Purchase CE


Cancellation Policy

Event registration cancellations received on or before February 25, 2024 (2/25/24) will receive a full refund less a 8% processing fee. Cancellations received between February 26, 2024 and March 26, 2024 (2/26/24-3/26/24) will receive a 50% refund. Cancellations made on or after March 27, 2024 (3/27/24) will not receive a refund. All Continuing Education registrations will be refunded in full less an 8% processing fee regardless of date.

All cancellation requests must be made in writing and emailed to: events@acmt.net. No telephone cancellations will be accepted. A refund that results from a cancellation or change to your registration will be returned to the original payer and in the original method of payment.

Pending review, limited exceptions will be made based on need and circumstance and must be submitted in writing to events@acmt.net. Because each exception must undergo a review and approval process, we ask in advance for your patience.


Questions?

Write to: events@acmt.net

Continuing Education

image

Continuing Education credit for this activity will be provided by AKH Inc., Advancing Knowledge in Healthcare. 


image

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and American College of Medical Toxicology (ACMT). AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. If you are seeking continuing education credit for a specialty not listed above, it is your responsibility to contact your licensing/certification board to determine course eligibility for your licensing/certification requirement.

CME, CPE, and CNE Continuing Education credits are pending for this activity. It is expected that learners will receive up to 21.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

 Purchase CE

Venue Info

The 2024 ACMT Annual Scientific Meeting will take place at the Omni Shoreham Hotel in Washington, DC.

Omni Shoreham Hotel
2500 Calvert St NW
Washington, DC 20008

Google map link


Booking Link

ACMT has secured a discounted rate for attendees of our 2024 ACMT Annual Scientific Meeting. We encourage you to book your stay at the Omni Shoreham using the link below for the best selection and price!

Book Attendee Hotel

Exclusive hotel rate expires: March 18, 2024


Explore DC

The landmark Omni Shoreham Hotel is located in Washington D.C.’s premier "Woodley" residential neighborhood. An icon among hotels in Washington, D.C., the Omni Shoreham Hotel has hosted presidents, world leaders and inaugural balls since its inception in the 1930s. Hotel amenities include a heated resort pool, relaxation gardens, a state-of-the art fitness center, and a massage therapy spa. The city’s most popular attractions are also nearby - including the National Zoo, the White House, the United States Capitol and the National Mall.

Download Woodley Area & Metro Map brochure

Key:

Complete
Failed
Available
Locked
Live In-Person Event
04/12/2024 at 7:45 AM (EDT)   |  2 days, 5 hours, 45 minutes  |  Attendance Required
04/12/2024 at 7:45 AM (EDT)   |  2 days, 5 hours, 45 minutes  |  Attendance Required
Drug Toxicity from Pharmaceutical Production Processes (EAPCCT)
Open to view video.  |  37 minutes
Open to view video.  |  37 minutes Full on-demand lecture for Drug Toxicity from Pharmaceutical Production Processes (EAPCCT) by Dr. Mark Lawerence Zammit.